Menu
Search
|

Menu

Close
X

Sonoma Pharmaceuticals Inc SNOA.OQ (NASDAQ Stock Exchange Capital Market)

2.45 USD
-- (--)
As of Jul 16
chart
Previous Close 2.45
Open --
Volume --
3m Avg Volume 21,731
Today’s High --
Today’s Low --
52 Week High 7.00
52 Week Low 2.33
Shares Outstanding (mil) 6.42
Market Capitalization (mil) 15.92
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
17
FY17
14
FY16
13
FY15
14
EPS (USD)
FY18
-3.138
FY17
-1.729
FY16
-3.620
FY15
-4.473
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.15
Price to Sales (TTM)
vs sector
0.96
8.04
Price to Book (MRQ)
vs sector
1.00
4.28
Price to Cash Flow (TTM)
vs sector
--
22.37
Total Debt to Equity (MRQ)
vs sector
3.61
17.43
LT Debt to Equity (MRQ)
vs sector
1.15
13.25
Return on Investment (TTM)
vs sector
-75.18
13.23
Return on Equity (TTM)
vs sector
-77.96
15.27

EXECUTIVE LEADERSHIP

James Schutz
President, Chief Executive Officer, Director, Since 2013
Salary: $250,000.00
Bonus: --
Robert Miller
Chief Financial Officer, Secretary, Since 2018
Salary: $250,000.00
Bonus: --
Marc Umscheid
Chief Operating Officer, Since 2018
Salary: --
Bonus: --
Robert Northey
Executive Vice President - Research and Development, Since 2014
Salary: $194,000.00
Bonus: $20,000.00
Bruce Thornton
Executive Vice President - International Operations and Sales, Since 2008
Salary: $250,000.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

1129 N Mcdowell Blvd
PETALUMA   CA   94954-1110

Phone: +1707.2830550

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets solutions for management of dermatological conditions and advanced tissue care. The Company's product portfolio consists of dermatology, animal health, and advanced tissue care products based upon its Microcyn technology. Its Microcyn technology family of products consists of liquids and gels, which contain small molecule oxychlorine compounds. Its products serve patients across the globe by reducing infections, itch, pain, scarring and inflammatory responses. Its products are sold throughout the United States and internationally.

SPONSORED STORIES